WO2017199420A1 - Matériau fibreux antiviral et son procédé de fabrication - Google Patents

Matériau fibreux antiviral et son procédé de fabrication Download PDF

Info

Publication number
WO2017199420A1
WO2017199420A1 PCT/JP2016/065001 JP2016065001W WO2017199420A1 WO 2017199420 A1 WO2017199420 A1 WO 2017199420A1 JP 2016065001 W JP2016065001 W JP 2016065001W WO 2017199420 A1 WO2017199420 A1 WO 2017199420A1
Authority
WO
WIPO (PCT)
Prior art keywords
fiber material
antiviral
particles
silicone
antiviral fiber
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
PCT/JP2016/065001
Other languages
English (en)
Japanese (ja)
Inventor
宮本博
野間基久
廣末睦
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
KB TSUZUKI KK
Original Assignee
KB TSUZUKI KK
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by KB TSUZUKI KK filed Critical KB TSUZUKI KK
Priority to PCT/JP2016/065001 priority Critical patent/WO2017199420A1/fr
Priority to JP2018518036A priority patent/JPWO2017199420A1/ja
Publication of WO2017199420A1 publication Critical patent/WO2017199420A1/fr
Anticipated expiration legal-status Critical
Ceased legal-status Critical Current

Links

Classifications

    • D—TEXTILES; PAPER
    • D06—TREATMENT OF TEXTILES OR THE LIKE; LAUNDERING; FLEXIBLE MATERIALS NOT OTHERWISE PROVIDED FOR
    • D06M—TREATMENT, NOT PROVIDED FOR ELSEWHERE IN CLASS D06, OF FIBRES, THREADS, YARNS, FABRICS, FEATHERS OR FIBROUS GOODS MADE FROM SUCH MATERIALS
    • D06M11/00—Treating fibres, threads, yarns, fabrics or fibrous goods made from such materials, with inorganic substances or complexes thereof; Such treatment combined with mechanical treatment, e.g. mercerising
    • D06M11/32—Treating fibres, threads, yarns, fabrics or fibrous goods made from such materials, with inorganic substances or complexes thereof; Such treatment combined with mechanical treatment, e.g. mercerising with oxygen, ozone, ozonides, oxides, hydroxides or percompounds; Salts derived from anions with an amphoteric element-oxygen bond
    • D06M11/36—Treating fibres, threads, yarns, fabrics or fibrous goods made from such materials, with inorganic substances or complexes thereof; Such treatment combined with mechanical treatment, e.g. mercerising with oxygen, ozone, ozonides, oxides, hydroxides or percompounds; Salts derived from anions with an amphoteric element-oxygen bond with oxides, hydroxides or mixed oxides; with salts derived from anions with an amphoteric element-oxygen bond
    • D06M11/44—Oxides or hydroxides of elements of Groups 2 or 12 of the Periodic Table; Zincates; Cadmates
    • D—TEXTILES; PAPER
    • D06—TREATMENT OF TEXTILES OR THE LIKE; LAUNDERING; FLEXIBLE MATERIALS NOT OTHERWISE PROVIDED FOR
    • D06M—TREATMENT, NOT PROVIDED FOR ELSEWHERE IN CLASS D06, OF FIBRES, THREADS, YARNS, FABRICS, FEATHERS OR FIBROUS GOODS MADE FROM SUCH MATERIALS
    • D06M15/00—Treating fibres, threads, yarns, fabrics, or fibrous goods made from such materials, with macromolecular compounds; Such treatment combined with mechanical treatment
    • D06M15/19—Treating fibres, threads, yarns, fabrics, or fibrous goods made from such materials, with macromolecular compounds; Such treatment combined with mechanical treatment with synthetic macromolecular compounds
    • D06M15/37—Macromolecular compounds obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds
    • D06M15/643—Macromolecular compounds obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds containing silicon in the main chain

Definitions

  • the present invention relates to an antiviral fiber material and a method for producing the same.
  • Virus is a microorganism that causes disease by infection, as is well known. Vaccination is effective in preventing disease, but vaccines effective against influenza viruses are often insufficient in winter. For this reason, the antiviral material which can prevent being infected with a virus itself is calculated
  • JP 2013-67618 A and JP 2009-526828 A disclose inorganic materials on the surface of fiber materials such as face masks, hats, hoods, trousers, shirts, gloves, skirts, boiler suits, and surgical clothes (scrubs).
  • An antiviral material coated with nanoparticles composed of the above has been proposed.
  • the inorganic substance include oxides such as Ca, Al, Zn, Ni, W, and Cu, nitrides, carbides, and the like.
  • the nanoparticles perform a filter action (blocking action) for blocking viruses.
  • the user wearing the fiber material may be prevented from suffering from a disease caused by a virus.
  • JP 2013-67618 A and JP 2009-526828 A suggest that nanoparticles that have come into contact with a virus may inactivate the virus.
  • JP 2013-67618 A and JP 2009-526828 A describe that nanoparticles are coated on a fiber material by a technique such as spraying, electrospraying, dipping, or plasma treatment.
  • a solution or dispersion in which nanoparticles are added to a solvent or dispersion medium is prepared, and the fiber is passed through this preparation. It is presumed that after the nanoparticles are attached to the surface of the material, an operation of evaporating the preparation liquid is performed.
  • the main object of the present invention is to provide an antiviral fiber material exhibiting antiviral ability against various types of viruses.
  • Another object of the present invention is to provide an antiviral fiber material that does not have a concern of releasing substances that cause health problems of animals and plants.
  • Another object of the present invention is to provide a method for producing the above-described antiviral fiber material.
  • aluminum oxide-doped zinc oxide (hereinafter sometimes referred to as “Al—ZnO”) particles on the surface of a fiber material are polyoxyethylene having 12 to 15 carbon atoms.
  • Al—ZnO aluminum oxide-doped zinc oxide
  • Antiviral ability is obtained by Al-ZnO particles. Therefore, it is expected that by wearing the above-mentioned antiviral fiber material, it is possible to prevent suffering from diseases caused by viruses. Moreover, since the Al—ZnO particles are harmless, there is no concern that substances causing health problems of animals and plants are released from the antiviral fiber material. For this reason, it is possible to avoid the health disorder resulting from an antiviral fiber material, avoiding the disease affliction resulting from a virus.
  • the silicone film easily expands and contracts following the deformation of the fiber material. For this reason, the state firmly fixed to the surface of the fiber material can be maintained. Therefore, even when a frictional force or the like is applied to the antiviral fiber material in water or in medicine during washing or dyeing, the silicone film is suppressed from being detached from the surface of the fiber material. Accordingly, the Al—ZnO particles held on the silicone film are also difficult to separate from the surface of the fiber material. For this reason, antiviral ability lasts for a long time.
  • the silicone film is fixed to the fiber material mainly by a mechanical action such as an anchor effect.
  • the majority of functional groups in the fibers constituting the fiber material exist in a state where no chemical bond such as a covalent bond is formed with the silicone film. Therefore, when the modified fiber is dyed, the functional group and the dye can sufficiently react, and the dye can be satisfactorily dyed while avoiding color unevenness. Therefore, this antiviral fiber material is excellent in dyeability and can be easily post-dyed.
  • the silicone film is a porous body having a plurality of microporous layers, and the surface has a scaly shape. Moisture easily spreads on the surface of the silicone film having such a shape. Also, moisture is absorbed by the microporous. Therefore, the antiviral fiber material has good water absorption.
  • This antiviral fiber material is mainly antiviral against influenza A virus. Therefore, it is expected that the patient can be prevented from suffering from influenza A by wearing the antiviral fiber material.
  • zeolite particles holding silver ions may be held on the surface of the fiber material via the silicone membrane. Good. In this case, not only Al—ZnO particles but also Ag zeolite particles exhibit the action virus ability. Ag zeolite particles are also harmless. Therefore, even in this case, there is no concern that substances causing health problems of animals and plants are released from the antiviral fiber material. That is, it is possible to avoid health problems caused by the antiviral fiber material as described above.
  • the antiviral fiber material exhibits antiviral properties against, for example, feline calicivirus.
  • the fiber material constituting the antiviral fiber material may include at least one of cellulosic fibers or animal fibers. This type of natural fiber is difficult to post-dye, but by forming a silicone film on the surface as described above, it becomes an anti-viral fiber material that is easy to post-dye while exhibiting anti-viral ability.
  • silicone particles having a polyoxyethylene alkyl ether having 12 to 15 carbon atoms as a main component and having a siloxane skeleton and zinc oxide particles doped with aluminum are dispersed. Immersing the fiber material in the aqueous dispersion; A step of forming a silicone film from the silicone particles by heat treatment, holding the zinc oxide particles on the surface of the fiber material through the silicone film, and obtaining an antiviral fiber material exhibiting antiviral properties; A method for producing an antiviral fiber material having the following is provided.
  • the Al—ZnO particles can be held on the surface of the fiber material through the silicone film. That is, an antiviral fiber material is obtained.
  • the zeolite particles retaining silver ions may be further added to the aqueous dispersion.
  • an antiviral fiber material in which both Al—ZnO particles and Ag zeolite particles are held on the surface of the fiber material through the silicone film can be easily obtained.
  • the heat treatment is preferably performed by a steam set using water vapor.
  • the silicone particles can be cross-linked using saturated steam at 100 ° C. or lower.
  • the natural fiber when natural fiber is contained in the fiber material, the natural fiber can be prevented from shrinking.
  • the generation of active oxygen is suppressed by filling the atmosphere around the natural fiber with saturated steam.
  • the fiber material may include at least one of cellulosic fibers or animal fibers.
  • the anti-viral ability based on the Al—ZnO particles can be obtained in the fiber material. That is, an antiviral fiber material is constituted.
  • the Al—ZnO particles are held via the silicone film. For this reason, Al—ZnO particles are unlikely to fall off the surface of the fiber material. Therefore, antiviral ability is sustained over a long period.
  • the fiber material can be easily dyed after dyeing and has excellent hygroscopicity.
  • the antiviral fiber material according to the first embodiment exhibits antiviral ability by using zinc oxide doped with aluminum (Al-ZnO) as an active ingredient.
  • ZnO is generally an insulator
  • Al-ZnO is an n-type semiconductor.
  • the antiviral fiber material is configured by holding Al—ZnO particles on the surface of the fiber material.
  • Al—ZnO particles are commercially available, with a typical average particle size of approximately 120 ⁇ m.
  • the average particle diameter is a numerical value measured by a commercially available particle size analyzer or the like, for example, a particle diameter at an integrated value of 50% (D50) in a particle size distribution obtained by a laser diffraction / scattering method.
  • the fiber material includes at least one of cellulosic fibers, animal fibers, and synthetic fibers. That is, the fiber material may be composed only of cellulosic fibers, animal fibers, or synthetic fibers, or may include two or more of these.
  • Typical cellulosic fibers include natural plant fiber cotton (cotton). Or hemp such as ramie, linen, cannabis (hemp), jute, manila hemp and sisal hemp may be used.
  • the cellulosic fiber may be a so-called regenerated fiber obtained by dissolving natural cellulose with a predetermined solvent and then forming it into a fiber shape. Specific examples of this type of regenerated fiber include rayon, polynosic, cupra, and tencel (registered trademark of the Austrian ranging company).
  • animal fibers include silk, wool, and animal hair fibers.
  • Specific animal hair fibers include alpaca, mohair, angora, cashmere, camel, bucuna, and the like.
  • examples of synthetic fibers include polyesters, polyurethanes, aliphatic polyamide fibers (including nylon 6, nylon 6, 6), aromatic polyamide fibers, and the like.
  • the ratio of cellulosic fibers, animal fibers, and synthetic fibers in the fiber material is not particularly limited, and can be set to a desired ratio.
  • the shape of the fiber material is not particularly limited, and includes yarn, cotton (cotton), sliver, woven fabric, knitted fabric, non-woven fabric, and the like.
  • the fiber material may be one in which the original yarns (mixed yarn or intertwisted yarn) of both fibers are woven, or cellulosic fibers A cross woven fabric using a raw yarn and an animal fiber yarn may be used.
  • Al—ZnO is held on the surface of the fiber material as described above via a silicone film.
  • This silicone film is made of silicone having a polyoxyethylene alkyl ether having 12 to 15 carbon atoms as a main component and having a siloxane skeleton.
  • the silicone film is a porous body having a plurality of microporous materials and has a scaly surface.
  • the silicone film is physically fixed to the surface of the fiber material mainly by a mechanical action such as an anchor effect. That is, the majority of the functional groups of the fiber material are not chemically bonded to the silicone functional groups of the silicone membrane. For this reason, since the functional group of a fiber material shows sufficient activity with respect to dye, an antiviral fiber material can be dye
  • the silicone film has a scaly shape, moisture spreads well on the surface.
  • the silicone membrane is a porous body, and moisture penetrates into the microporous material.
  • the functional group of the fiber material is hydrophilic and functions to attract water molecules. For the above reasons, the antiviral fiber material is excellent in hygroscopicity.
  • the silicone film shows good elasticity. Therefore, when the fiber material is deformed, the silicone film expands and contracts following the deformation. That is, since the state in which the silicone film is firmly fixed to the surface of the fiber material is maintained, the state in which the Al—ZnO particles are held on the fiber material through the silicone film is maintained.
  • the silicone film and Al—ZnO particles may fall off the surface of the fiber material. It is suppressed. As a result, antiviral ability lasts for a long time.
  • the antiviral fiber material according to the first embodiment in particular inactivates influenza A virus. For this reason, it is possible to prevent a user wearing a fiber material from suffering from influenza A. Moreover, this antiviral ability lasts for a long time. This is because, as described above, the silicone film and the Al—ZnO particles are difficult to drop off from the surface of the fiber material.
  • influenza A virus has a nucleic acid encapsulated by capsids as RNA and an envelope.
  • the antiviral fiber material according to the first embodiment can be obtained as follows. That is, first, an aqueous dispersion is prepared by dispersing silicone particles having a polyoxyethylene alkyl ether having 12 to 15 carbon atoms as a main component and having a siloxane skeleton in an aqueous dispersion medium such as water.
  • This type of aqueous dispersion can be obtained by adjusting commercially available products such as “X-51-1318” (trade name of a silicone-containing reactive softener manufactured by Shin-Etsu Chemical Co., Ltd.) to an appropriate concentration. .
  • the concentration of the silicone particles may be, for example, 0.1 to 10% by mass.
  • Al—ZnO particles are added and dispersed.
  • Al—ZnO particles for example, a commercially available product such as “Z-SDN” (manufactured by Satoda Chemical Co., Ltd.) may be used.
  • the concentration of Al—ZnO particles can be set to 0.1 to 30% by mass, for example.
  • the fiber material is immersed in the aqueous dispersion thus prepared. Thereby, silicone particles and Al—ZnO particles adhere to the surface of the fiber material. Thereafter, a squeezing solution is performed, and further a drying process and a heating process are performed. By the heat treatment, the silicone particles are cross-linked to form a silicone film, and the Al—ZnO particles are held on the surface of the fiber material through the silicone film. As a result, an antiviral fiber material is obtained.
  • the heat treatment may be performed using, for example, existing heating equipment such as a heat setter, but is more preferably performed by steam setting using water vapor.
  • existing heating equipment such as a heat setter
  • saturated steam at 100 ° C. or lower is used, an antiviral fiber material with further improved flexibility can be obtained.
  • saturated steam can enter even if it is the gap
  • the saturated vapor is filled around the fiber material, so that generation of active oxygen or the like is suppressed. For this reason, it is possible to effectively avoid damage and embrittlement due to the influence of the active oxygen on the fiber material.
  • the antiviral fiber material obtained through the above process is physically bonded to the surface of the fiber material mainly by the anchor effect, and can freely expand and contract following the deformation of the fiber material.
  • Al—ZnO particles are held through the silicone film.
  • the Al—ZnO particles exhibit an antiviral ability that is particularly effective against influenza A virus.
  • this antiviral fiber material is in a state in which the functional group of the fiber material can be chemically bonded to the dye, it has excellent dyeability and can be easily post-dyed.
  • the antiviral fiber material according to the second embodiment is configured by holding Al—ZnO particles and silver (zeolite) particles (aluminosilicate) particles held on the surface of the fiber material via a silicone film.
  • Al—ZnO and Ag zeolite are active ingredients.
  • Al—ZnO, the silicone film and the fiber material are as described above, and thus detailed description thereof is omitted.
  • Zeolite is a porous body having a large number of pores on its surface, and silver is held in the pores.
  • This kind of Ag zeolite particles are commercially available, its composition formula is represented by XAgO ⁇ Al 2 O 3 ⁇ YSiO 2 ⁇ ZH 2 O.
  • X, Y and Z are molar ratios.
  • the antiviral fiber material holding Ag zeolite exhibits excellent antiviral ability against influenza A virus and feline calicivirus. And since a silicone film
  • the nucleic acid encapsulated by the capsid is RNA and has no envelope. That is, the antiviral fiber material according to the second embodiment can inactivate both an influenza A virus having an envelope and a feline calicivirus not having an envelope.
  • the antiviral fiber material according to the second embodiment can be obtained according to the first embodiment. That is, an aqueous dispersion in which silicone particles are dispersed is prepared, and Al—ZnO particles and Ag zeolite particles are added to the aqueous dispersion. Either Al—ZnO particles or Ag zeolite particles may be added first, or both may be added simultaneously.
  • Ag zeolite particles examples include “ZEOMIC WAW10NS” (manufactured by Sinanen Zeomic).
  • the concentration of Ag zeolite particles can be set to 0.1 to 30% by mass, for example.
  • the fiber material is immersed in the aqueous dispersion. Thereby, silicone particles, Al—ZnO particles, and Ag zeolite particles adhere to the surface of the fiber material. Thereafter, in accordance with the first embodiment, heat treatment using a steam set or the like is performed to obtain an antiviral fiber material in which Al—ZnO particles and Ag zeolite particles are held on the surface of the fiber material via a silicone film. It is done.
  • this antiviral fiber material similarly to the above, physically bonded mainly to the surface of the fiber material by the anchor effect, and through a silicone film that can freely expand and contract following the deformation of the fiber material, Al—ZnO particles and Ag zeolite particles are retained.
  • the anti-viral ability that is particularly effective against influenza A virus is expressed by the Al—ZnO particles.
  • Ag zeolite particles are particularly effective against feline calicivirus, but are also effective against influenza A virus.
  • a Ag zeolite particles are also harmless as shown in the Material Safety Data Sheet (MSDS). Therefore, also in the second embodiment, there is no concern that a substance causing health problems of animals and plants is released from the antiviral fiber material. Therefore, similarly to the first embodiment, it is possible to avoid causing a health disorder due to the antiviral fiber material while avoiding suffering from a disease due to a virus.
  • MSDS Material Safety Data Sheet
  • this antiviral fiber material is excellent in dyeability and can be easily post-dyed for the same reason as the antiviral fiber material according to the first embodiment.
  • polyester 20 plain weave, 20th single yarn is warp, 20th single yarn is weft (20/1 x 20/1), warp is 90 / inch, and weft is 58 A fabric which is / inch is obtained. This is designated as fiber material B.
  • polyester 30 plain weave, 30th single yarn is warp, 30th single yarn is weft (30/1 x 30/1), warp is 110 / inch, and weft is 83 A fabric which is / inch is obtained. This is designated as fiber material C.
  • the above fiber materials A to C were individually scoured, bleached, dehydrated and dried.
  • a first aqueous dispersion, a second aqueous dispersion for fiber material A, and a second aqueous dispersion for fiber material B were separately prepared.
  • the first aqueous dispersion is obtained by adding X-51-1318 and Z-SDN to water so that the respective concentrations become 5% by mass and 20% by mass.
  • the second aqueous dispersion for the fiber material A was added with X-51-1318, Z-SDN, and ZEOMIC WAW10NS to water so that the respective concentrations were 2 mass%, 10 mass%, and 10 mass%.
  • the second aqueous dispersion for fiber material B the same components as in the second aqueous dispersion for fiber material A are used so that their concentrations are 5% by mass, 20% by mass, and 20% by mass, respectively. Is added to.
  • the fiber material C was immersed in the first aqueous dispersion. Thereafter, heat treatment was performed with a steam set, and Al—ZnO particles and Ag zeolite particles were held on the surfaces of the fiber materials A and B via a silicone film. In addition, Al—ZnO particles were held on the surface of the fiber material C through a silicone film.
  • the plaque method based on ISO18184 was performed on the fiber materials A and B among them. Specifically, 0.2 ml of a test virus suspension was inoculated into 0.4 g of a test piece individually cut out from the fiber materials A and B, and allowed to stand at 25 ° C. for 2 hours. Thereafter, the washing solution was added and stirred, and the virus was recovered from the test piece as a solution.
  • This virus recovery solution was diluted 10 times to prepare a diluted solution, and the diluted solution was inoculated to the monolayer cultured cells. After culturing at 37 ° C. for 1 hour, the virus was adsorbed to the cells. Thereafter, cell culture agar medium was added, and the cells were cultured at 37 ° C. under 5% CO 2 for 2 to 3 days.
  • the antiviral activation values of the fiber materials A and B were 3.7 and 3.8, respectively. Since it is recognized that an antiviral fiber material is effective when the antiviral activation value is 3.0 or more, it is determined that both of the fiber materials A and B exhibit sufficient antiviral ability.
  • the antiviral activation value against feline calicivirus was also measured. As a result, it was 3.5. From this result, it can be seen that the fiber material B simultaneously holding the Al—ZnO particles and the Ag zeolite particles exhibits an effective antiviral ability against both an influenza A virus having an envelope and a feline calicivirus having no envelope.
  • Influenza A virus was inoculated into the chorioallantoic cavity, which is difficult to develop, and after incubation with an incubator, chorioallantoic fluid was collected and purified by density gradient centrifugation.
  • This virus solution was diluted with phosphate buffered saline supplemented with 0.05% of the surfactant Twin 80 (Tween 80, trade name of Tokyo Chemical Industry Co., Ltd.) to obtain a test virus solution.
  • test piece of the fiber material C was put in a 50 ml centrifuge tube, 0.2 ml of a test virus solution of 2.9 ⁇ 10 9 TCID 50 / ml was permeated into the test piece, and a thermostat set at 25 ° C. It was allowed to stand for 24 hours. After 24 hours, the test piece was placed in a plastic bag for stomacher, 10 ml of SCDLP medium was added as an operation stop solution, and the mixture was squeezed for 2 minutes to induce the virus. The elicited solution was collected in a test tube, centrifuged at 1500 rpm for 3 minutes, and the supernatant was used as a sample stock solution for infectivity titration measurement.
  • the infectious titer sample stock solution After serially diluting the infectious titer sample stock solution 10 times with PBS, 25 ⁇ L of the infectious titer sample stock solution or diluted virus solution is added to MDCK cells previously cultured in a monolayer in a 96-well plate, and then at 37 ° C. for 1 hour. Infected. Next, the inoculated virus solution was removed, 100 ⁇ L of MEM supplemented with 0.42% BSA and 2.5 ⁇ g / mL trypsin was added, and the cells were cultured at 37 ° C. under 5% CO 2 for 4 days.
  • the cytopathic effect due to virus proliferation was observed under an inverted microscope, and the virus infectivity titer, that is, TCID 50 / mL was determined by the TCID calculation method (Reed-Muench method).
  • the TCID calculation method Reed-Muench method

Landscapes

  • Engineering & Computer Science (AREA)
  • Textile Engineering (AREA)
  • Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Chemical Or Physical Treatment Of Fibers (AREA)
  • Treatments For Attaching Organic Compounds To Fibrous Goods (AREA)

Abstract

La présente invention concerne un matériau fibreux antiviral qui présente des propriétés antivirales contre des virus de divers types. La surface de ce matériau fibreux retient au moins des particules d'oxyde de zinc dopé à l'aluminium (particules Al-ZnO). En outre, il est préférable que des particules de zéolite qui retiennent de l'argent (particules Ag zéolite) soient retenues. Les particules Al-ZnO et les particules Ag zéolite sont retenues sur la surface du matériau fibreux avec un film de silicone interposé. Le film de silicone est formé de silicone qui possède des éthers d'alkyle de polyoxyéthylène de 12 à 15 atomes de carbone en tant que composant principal et possède un squelette de siloxane.
PCT/JP2016/065001 2016-05-20 2016-05-20 Matériau fibreux antiviral et son procédé de fabrication Ceased WO2017199420A1 (fr)

Priority Applications (2)

Application Number Priority Date Filing Date Title
PCT/JP2016/065001 WO2017199420A1 (fr) 2016-05-20 2016-05-20 Matériau fibreux antiviral et son procédé de fabrication
JP2018518036A JPWO2017199420A1 (ja) 2016-05-20 2016-05-20 抗ウイルス性繊維材及びその製造方法

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
PCT/JP2016/065001 WO2017199420A1 (fr) 2016-05-20 2016-05-20 Matériau fibreux antiviral et son procédé de fabrication

Publications (1)

Publication Number Publication Date
WO2017199420A1 true WO2017199420A1 (fr) 2017-11-23

Family

ID=60324888

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/JP2016/065001 Ceased WO2017199420A1 (fr) 2016-05-20 2016-05-20 Matériau fibreux antiviral et son procédé de fabrication

Country Status (2)

Country Link
JP (1) JPWO2017199420A1 (fr)
WO (1) WO2017199420A1 (fr)

Cited By (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2021070798A (ja) * 2019-11-01 2021-05-06 イビデン株式会社 抗ウィルス性部材及び抗ウィルス性部材の製造方法
JP2022051507A (ja) * 2020-09-18 2022-03-31 株式会社イノアックコーポレーション ポリウレタンフォームとその製造方法
CN115427629A (zh) * 2020-04-24 2022-12-02 赛杰法拉利股份有限公司 包含含银的硅酮表面层或氟化聚合物的复合膜，其生产方法及其作为抗病毒剂的用途
WO2025109688A1 (fr) * 2023-11-21 2025-05-30 Ｋｂツヅキ株式会社 Procédé d'évaluation de matériau fibreux

Citations (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS6039486A (ja) * 1983-07-16 1985-03-01 チバ‐ガイギ　アクチエンゲゼルシヤフト 繊維材料の処理方法
JPH0717816A (ja) * 1993-06-30 1995-01-20 Mitsubishi Materials Corp 抗菌防黴性粉末
JP2002104823A (ja) * 2000-09-28 2002-04-10 Hakusui Tech Co Ltd 抗菌・防黴剤
JP2009526828A (ja) * 2006-02-16 2009-07-23 クイーン メアリー アンド ウェストフィールド カレッジ 殺ウイルス材料
JP2011246859A (ja) * 2010-05-28 2011-12-08 Suminoe Textile Co Ltd 抗菌、抗ウイルスおよび抗アレルゲン機能を有する繊維布帛
JP3179060U (ja) * 2012-08-02 2012-10-11 株式会社シガドライウィザース 抗ウイルス織物、それを素材として作られた衣類、カーテン及び網戸
JP5576584B1 (ja) * 2013-12-03 2014-08-20 Ｋｂツヅキ株式会社 改質繊維及びその製造方法

Patent Citations (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS6039486A (ja) * 1983-07-16 1985-03-01 チバ‐ガイギ　アクチエンゲゼルシヤフト 繊維材料の処理方法
JPH0717816A (ja) * 1993-06-30 1995-01-20 Mitsubishi Materials Corp 抗菌防黴性粉末
JP2002104823A (ja) * 2000-09-28 2002-04-10 Hakusui Tech Co Ltd 抗菌・防黴剤
JP2009526828A (ja) * 2006-02-16 2009-07-23 クイーン メアリー アンド ウェストフィールド カレッジ 殺ウイルス材料
JP2011246859A (ja) * 2010-05-28 2011-12-08 Suminoe Textile Co Ltd 抗菌、抗ウイルスおよび抗アレルゲン機能を有する繊維布帛
JP3179060U (ja) * 2012-08-02 2012-10-11 株式会社シガドライウィザース 抗ウイルス織物、それを素材として作られた衣類、カーテン及び網戸
JP5576584B1 (ja) * 2013-12-03 2014-08-20 Ｋｂツヅキ株式会社 改質繊維及びその製造方法

Cited By (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2021070798A (ja) * 2019-11-01 2021-05-06 イビデン株式会社 抗ウィルス性部材及び抗ウィルス性部材の製造方法
JP7486302B2 (ja) 2019-11-01 2024-05-17 イビデン株式会社 抗ウィルス性部材及び抗ウィルス性部材の製造方法
CN115427629A (zh) * 2020-04-24 2022-12-02 赛杰法拉利股份有限公司 包含含银的硅酮表面层或氟化聚合物的复合膜，其生产方法及其作为抗病毒剂的用途
JP2022051507A (ja) * 2020-09-18 2022-03-31 株式会社イノアックコーポレーション ポリウレタンフォームとその製造方法
WO2025109688A1 (fr) * 2023-11-21 2025-05-30 Ｋｂツヅキ株式会社 Procédé d'évaluation de matériau fibreux

Also Published As

Publication number Publication date
JPWO2017199420A1 (ja) 2019-03-14

Similar Documents

Publication Publication Date Title
JPWO2017199420A1 (ja) 抗ウイルス性繊維材及びその製造方法
KR102263195B1 (ko) 항균원단 및 그 제조방법
US9481961B2 (en) Antimicrobial finish on fabrics
El-Shafei et al. Herbal extract as an ecofriendly antibacterial finishing of cotton fabric
AU2019247408B2 (en) Durable antimicrobial treatment of textile for use in healthcare environment
CN102168341A (zh) 一种驱虫抗菌面料的生产工艺
Ibrahim et al. Aloe vera leaf gel extract for antibacterial and softness properties of cotton
CN115162007B (zh) 一种自交联型纺织品抗菌防紫外整理剂及其制备方法
JP2005009065A (ja) 抗菌・殺菌性繊維製品及びその製造方法
CN111335044A (zh) 缓释微胶囊及其制备方法和含有该缓释微胶囊的整理剂及其制备方法和应用
CN118147919A (zh) 一种持久抗菌、抑螨、驱蚊的纤维素纤维织物及制备方法
CN102899764A (zh) 一种腈纶、苎麻纤维和大豆蛋白纤维混纺纱
JP7697906B2 (ja) 加工剤、処理剤、加工物品ならびに加工物品の製造方法
JPH023602A (ja) 防虫ストッキング
Kalahroodi et al. Viruses and bacteria–antiviral and antibacterial textile materials: A Review
WO2025243881A1 (fr) Procédé de production d'une structure de fibre antibactérienne/antifongique, et structure de fibre antibactérienne/antifongique
Karolia et al. Antibacterial properties of natural dyes on cotton fabrics
JP2022098204A (ja) 抗ウィルス繊維構造体およびその製造方法、抗ウィルス加工製品
CN118461314A (zh) 一种抗菌凉感纤维素纤维面料及其制备方法
CN111074409A (zh) 一种防蚊虫氨纶混纺针织面料及其生产方法
CN110685153B (zh) 防蛀纯羊绒面料及其制造方法
CN103882584A (zh) 一种氨纶、苎麻纤维和牛奶蛋白纤维混纺纱
Vijayalakshmi et al. Isolates application of multi-functional finishes on denim garments
CN113840552A (zh) 抗病毒纤维产品的制造方法和使用其制成的抗病毒口罩
Rukhaya et al. Durable aroma finishing of wool fabric with microencapsulated vetiver essential oil and assessment of its properties

Legal Events

Date Code Title Description
WWE Wipo information: entry into national phase

Ref document number: 2018518036

Country of ref document: JP

NENP Non-entry into the national phase

Ref country code: DE

121 Ep: the epo has been informed by wipo that ep was designated in this application

Ref document number: 16902439

Country of ref document: EP

Kind code of ref document: A1

122 Ep: pct application non-entry in european phase

Ref document number: 16902439

Country of ref document: EP

Kind code of ref document: A1